AMC Networks (AMCX) +6% Gains on Netflix Deal for The Walking Dead Universe
Key Takeaways
- AMC Networks shares have gained approximately 6% over the last 30 days, moving from around $10.26 in early July to roughly $10.90 in early August, driven largely by a landmark licensing agreement with Netflix.
- The company announced a five-year, $500 million co-exclusive global streaming deal with NFLX for the entire The Walking Dead universe, covering seven series and 371 episodes.
- Q2 2026 results reflected ongoing revenue pressure — consolidated revenue fell 9% year-over-year to $547.5 million — but management called the quarter the expected trough for adjusted operating income.
- Full-year 2026 guidance was raised materially: consolidated revenue of $2.40–$2.45 billion, adjusted operating income of $410–$420 million, and free cash flow of roughly $220 million.
- Wall Street remains cautious, with a consensus "Reduce" rating and an average 12-month price target of $8.50, though several analysts raised targets following the Netflix announcement.
- The stock hit a 52-week high of $11.66 on July 31 following the Q2 report and licensing news before settling near $10.90 in subsequent sessions.
Current Market Snapshot
AMC Networks, now operating under the brand name AMC Global Media, has seen its stock trade in a volatile range between roughly $9.30 and $11.66 over the past several weeks. After spending much of June and early July in the $9.30–$10.30 zone, shares surged more than 15% on July 31 when the company released second-quarter results alongside the Netflix licensing pact. The stock moved above its 200-day moving average of approximately $8.52 in mid-July and has stayed there since, reflecting a shift in sentiment. Even so, AMCX continues to trade at a modest price-to-sales multiple of approximately 0.25, which tells me the market is still skeptical about the durability of the legacy linear television business even as streaming and licensing show renewed momentum. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
AMC Networks (AMCX) Business Overview and Competitive Position
AMC Networks is a global entertainment company that develops, produces, and distributes premium content across television and streaming platforms. Its portfolio includes linear cable networks — AMC, WE tv, BBC America, IFC, and SundanceTV — as well as a growing suite of targeted direct-to-consumer streaming services: AMC+, Acorn TV, Shudder, Sundance Now, ALLBLK, HIDIVE, and All Reality. The company also operates AMC Studios, the in-house production arm behind major franchises including The Walking Dead and the Anne Rice Immortal Universe. Following international divestitures completed in 2023, domestic operations now account for nearly 90% of total revenue. The company differentiates itself by owning a deep library of original intellectual property and by catering to passionate niche audiences rather than competing head-to-head with large-scale general-entertainment streaming platforms. Investors track AMCX closely as a bellwether for how mid-tier media companies can monetize legacy content libraries in an increasingly streaming-first landscape.
Recent Developments Driving AMCX
The single most consequential event in the last 30 days was the July 30 disclosure of a five-year, $500 million global co-exclusive streaming licensing agreement with NFLX covering the entire The Walking Dead franchise — all seven series and 371 episodes. Under the terms, AMC Networks expects to recognize roughly $445 million in total revenue over the deal's life, with $200 million to $225 million recognized in both 2026 and 2027. The original Walking Dead series is also set to return to AMC+ in January 2027 for the first time.
The licensing news overshadowed otherwise weak second-quarter financial results. Consolidated revenue declined 9% year-over-year to $547.5 million, missing analyst estimates, while the company reported an adjusted loss of $0.28 per share. Domestic subscription revenue dropped 5% as a 17% decline in affiliate fees more than offset 6% streaming revenue growth. Advertising revenue was also pressured, though digital advertising grew 44% compared to the prior-year period.
On the analyst front, Morgan Stanley raised its price target to $10 from $7 while maintaining an Underweight rating, citing the deal's validation of AMC's intellectual property alongside ongoing concerns about subscriber growth and secular industry headwinds. Wells Fargo lifted its target to $11 from $10 with an Equal Weight rating. The broader analyst consensus remains cautious, with two Sell and two Hold ratings and an average price target of $8.50.
On the balance sheet, AMC repaid its remaining Term Loan A and terminated its credit facility during the quarter. The company ended Q2 with approximately $464 million in cash against roughly $1.3 billion in net debt, with approximately 75% of total debt not maturing until July 2032. From what I see, this debt profile provides some breathing room as the company executes on its new licensing strategy.
2026 Outlook and What Investors Should Watch
The raised full-year 2026 guidance — $2.40 billion to $2.45 billion in revenue, $410 million to $420 million in adjusted operating income, and roughly $220 million in free cash flow — sets a higher bar for the second half of the year. Management expects both revenue and profitability to improve from Q2 levels as licensing revenue from the Netflix deal begins flowing and distribution agreements with major pay-TV providers such as CMCSA and GOOG-owned YouTube take effect.
Key factors to monitor include the pace of affiliate revenue decline in the domestic linear business, the trajectory of streaming subscriber acquisition following the company's decision to stop reporting subscriber figures quarterly, and the sustainability of digital advertising growth. The company's ability to execute on content licensing beyond The Walking Dead will also be critical — investors will look for evidence that AMC can replicate its IP monetization playbook across other franchises, including the Anne Rice universe. Macroeconomic considerations such as advertising market health, consumer discretionary spending trends, and competitive dynamics in streaming remain important external variables. With net leverage at 4.1 times and a concentrated franchise portfolio, AMC's margin for operational missteps remains limited heading into 2027.
Using Tickeron’s Trending AI Robots
In my own research, I occasionally review Tickeron’s Trending AI Robots page to see how top-performing bots are positioned across various tickers. It offers a curated look at algorithmic strategies that can help put data-driven context around names like AMCX without adding emotional bias to the process.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
AMCX in downward trend: 10-day moving average moved below 50-day moving average on October 02, 2026
The 10-day moving average for AMCX crossed bearishly below the 50-day moving average on October 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 85%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 24, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AMCX as a result. In 70 of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.
AMCX moved below its 50-day moving average on September 29, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMCX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
The Aroon Indicator for AMCX entered a downward trend on October 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where AMCX's RSI Indicator exited the oversold zone, 39 of 46 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 85%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +1.33% 3-day Advance, the price is estimated to grow further. Considering data from situations where AMCX advanced for three days, in 209 of 279 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.
AMCX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. AMCX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 48 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.545) is normal, around the industry mean (18.508). P/E Ratio (11.523) is within average values for comparable stocks, (97.633). Projected Growth (PEG Ratio) (0.545) is also within normal values, averaging (3.885). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (0.271) is also within normal values, averaging (2.913).
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AMCX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
an operator of cable television networks through its subsidiaries
Industry MoviesEntertainment
Advertisement